Heksobendin
Izgled
| (IUPAC) ime | |||
|---|---|---|---|
| etan-1,2-diilbis[(metilimino)propan-3,1-diil] bis(3,4,5-trimetoksibenzoat) | |||
| Klinički podaci | |||
| Identifikatori | |||
| ATC kod | C01DX06 | ||
| PubChem[1][2] | 5777 | ||
| UNII | B6X4SYR93B | ||
| Hemijski podaci | |||
| Formula | C30H44N2O10 | ||
| Mol. masa | 592,68 g/mol | ||
| SMILES | eMolekuli & PubHem | ||
| |||
| Farmakoinformacioni podaci | |||
| Trudnoća | ? | ||
| Pravni status | |||
Heksobendin je vazodilatator koji deluje kao inhibitor preuzimanja adenozina.[3]
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Kolassa N, Pfleger K (1975). „Adenosine uptake by erythrocytes of man, rat and guinea-pig and its inhibition by hexobendine and dipyridamole”. Biochemical Pharmacology 24: 154-156.